HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Bristol-Myers Squibb Company (BMY)
60.64  -0.13  (-0.21%) 10-20 18:36
Open: 61.09 High: 61.2684
Pre.close: 60.77 Low: 60.53
Volume: 6,492,797 Ave vol: 10,042,301
52w High: 68.34 52w Low: 45.76
MA(50): 59.883 MA(200): 60.115
EPS: -0.279 P/E Ratio: 0
Company profile
Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers General
Website: https://www.bms.com/
Market Cap (M): 136,678
Shares Out (M): 2,254
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in New York City, New York and currently employs 23,300 full-time employees. The firm's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The firm's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. The company offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. The Company’s subsidiary is Celgene Corp.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bearish
Target 1: 72.91 Target 2: 85.15
Resist 1: 62.42 Resist 2: 72.91
Support 1: 59.01 Support 2: 56.90
Company key metrics
Revenue per Share: 15.2716
Net Income per Share: 2.0088
Cash per Share: 7.2114
Book Value per Share: 30.139
Price to Sales: 4.1127
Price to Book Value: 2.0839
Earnings Yield: 0.032
Dividend Yield: 0.0249
Debt to Equity: 1.5184
Debt to Assets: 0.6029
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.